Recent Company News

• 02:36 AM ET Aug 25, 2025
  

  Teijin Pharma receives manufacturing and marketing approval in Japan for YORVIPATH as treatment for hypoparathyroidism (¥1286.0000, 0)

• 10:09 AM ET Aug 08, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (168 total)

• 04:32 PM ET Aug 07, 2025
  

  StreetAccount Summary - After-hours trading

• 04:05 PM ET Aug 07, 2025
  

  Ascendis Pharma reports Q2 EPS (€0.82) vs FactSet (€1.29) [15 est, (€1.91)-(0.79)] ($190.31, 0.00)

• 10:03 AM ET Aug 05, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (147 total)

• 08:58 AM ET Jul 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:01 AM ET Jul 28, 2025
  

  FDA Approves SKYTROFA (Lonapegsomatropin-tcgd) for the once-weekly treatment of adults with growth hormone deficiency ($167.47, 0.00)

• 05:21 PM ET Jul 25, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 10:58 AM ET Jul 25, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 27-Jul